SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-063689
Filing Date
2019-11-14
Accepted
2019-11-14 06:51:31
Documents
57
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17604_110q.htm 10-Q 1076230
2 EX-31.1 a19-17604_1ex31d1.htm EX-31.1 10915
3 EX-31.2 a19-17604_1ex31d2.htm EX-31.2 11553
4 EX-32.1 a19-17604_1ex32d1.htm EX-32.1 18019
  Complete submission text file 0001104659-19-063689.txt   5518790

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20190930.xml EX-101.INS 1340435
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20190930.xsd EX-101.SCH 42714
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20190930_cal.xml EX-101.CAL 41678
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20190930_def.xml EX-101.DEF 123610
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20190930_lab.xml EX-101.LAB 386621
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20190930_pre.xml EX-101.PRE 275090
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 191216277
SIC: 2834 Pharmaceutical Preparations